An Approach to Reduce Uvula Edema After Tonsillectomy
1 other identifier
interventional
30
1 country
1
Brief Summary
A prospective randomized clinical trial that included thirty subjects who underwent tonsillectomy. The patients in Group 1 (n:15) were injected with dexamethasone (1 ml, 8 mg) through the uvula and soft palate tissue directly before tonsillectomy. Group 2 (n:15) patients had tonsillectomy without dexamethasone injection. Patients were examined preoperatively and postoperative on the first and fifth days. In this study investigators tried an approach of dexamethasone application to reduce uvula edema after tonsillectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Jul 2018
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 9, 2017
CompletedFirst Posted
Study publicly available on registry
March 14, 2017
CompletedStudy Start
First participant enrolled
July 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 10, 2019
CompletedAugust 9, 2019
August 1, 2019
9 months
March 9, 2017
August 8, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Efficacy of local dexamethasone administration to reduce uvula edema after tonsillectomy evaluated by using the uvula edema scale
Uvula edema wase evaluated at the postoperative first and fifth days by using the uvula edema scale that the investigators developed.
Postoperative first and fifth days
Study Arms (2)
Group 1
ACTIVE COMPARATORThe patients in Group 1 (n:15) were injected with dexamethasone (1 ml, 8 mg) through the uvula and soft palate tissue directly at three points (three points on the connection of the uvula, and palatum molle) before tonsillectomy .
Group 2
NO INTERVENTIONGroup 2 (n:15) patients had tonsillectomy without dexamethasone injection.
Interventions
The patients in Group 1 were injected with dexamethasone (1 ml, 8 mg) through the uvula and soft palate tissue directly before tonsillectomy
Eligibility Criteria
You may qualify if:
- Subjects with recurrent tonsillitis but no sleep apnea
- Subjects older than eighteen years old
- Subjects were planned to have only tonsillectomy procedure
You may not qualify if:
- Subjects who must have additional procedures other than tonsillectomy
- Subjects younger than eighteen years old
- Subjects that had intravenous dexamethasone administration perioperatively
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bezmialem Vakif University
Istanbul, Fatih, 34093, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Selahattin Tugrul, Assoc. Prof.
Bezmialem Vakif University
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
March 9, 2017
First Posted
March 14, 2017
Study Start
July 15, 2018
Primary Completion
April 1, 2019
Study Completion
April 10, 2019
Last Updated
August 9, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will not share